Transforming Cancer Care
Transforming Cancer Care is a £157m investment in improving cancer care that will:
- Expand the services provided by The Clatterbridge Cancer Centre to meet the increasing demand for specialist cancer care as the population ages, and diagnosis and treatments improve.
- Develop a new Clatterbridge Cancer Centre in the heart of Liverpool, alongside Royal Liverpool University Hospital, the University of Liverpool and Cancer Research UK’s Liverpool Cancer Trials Unit. This would become The Clatterbridge Cancer Centre’s main site.
- Continue to provide outpatient treatment for most cancer at The Clatterbridge Cancer Centre in Wirral and its second radiotherapy unit at Aintree. Its chemotherapy clinics and outpatient clinics at local hospitals across Merseyside and Cheshire will also continue. The Wirral site will be redeveloped so patients continued to benefit from high-quality facilities.
How it will be funded
The £157m investment in Transforming Cancer Care isn’t just to build the new cancer hospital. It also includes redesign and refurbishment of our existing Wirral site, equipment and other capital costs. The capital cost for the new hospital in Liverpool is £129m.
Unlike many major hospital developments, Transforming Cancer Care is being funded entirely by the NHS with support from a major fundraising appeal, and is not a private finance initiative (PFI). The NHS funding is a combination of The Clatterbridge Cancer Centre’s own reserves, built up over many years, along with funding from commissioners and public sector borrowing from government sources.
Further information can be found on this dedicated website.